Continuous Noninvasive Blood Monitoring

When used in conjunction with other continuous, non-invasive monitoring technologies such as an electrocardiogram (ECG), pulse oximetry (SpO2), and end-tidal carbon dioxide (ETCO2) concentration in the expired air, the SmartPod provides continuous and comprehensive cardiovascular monitoring without the risk of invasive methods such as arterial lines. The monitor has received the European Community (CE) mark.

The new monitor integrates noninvasive arterial pressure continuous monitoring technology developed by CNSystems Medizintechnik (Graz, Austria) with Infinity patient monitoring developed by Dräger Medical Systems (Lübeck, Germany).

"One of the major trends in healthcare today is toward less-invasive care,” said Yossi Elaz, vice president of the monitoring and information technology (IT) competency center of Dräger. "Another trend is toward continuous, rather than intermittent monitoring. As a result of our alliance with CNSystems, we are pleased to offer our customers this noninvasive solution to continuous blood pressure monitoring, which is aligned with Dräger Medical's goal of being the leader in continuous and noninvasive monitoring technologies.”

"CNAP has brought real benefits to patients and physicians in the field of diagnostics as the core technology of our Task Force monitor, so bringing its advantages to patient monitoring was the logical next step,” said Jürgen Fortin, CEO of CNSystems.



Related Links:
CNSystems Medizintechnik
Dräger Medical Systems